Private company
ADAR1 Partners, LP
Hedge fund that raised $406.4 million in 2019 (SEC Form D), active since 2018. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersAustin, United States2
- Legal formLimited Partnership2
- Kind of organizationHedge fund2
- LEI2549009NGSLA9OOT9U062
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O HARVARD BUSINESS SERVICES, INC., 19958 Lewes, United States2
- Registered withSecurities and Exchange Commission, 00017588662
Corporate structure
ADAR1 Partners, LP sits at the top of its group. 9 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- ADAR1 Partners, LP Austin, Texas, United States
- Cellectar Biosciences, Inc. Stake · Madison, Wisconsin, United States
- FAST Acquisition Corp. Stake · Ridgefield, Connecticut
- iBio, Inc. Stake · Dover, Delaware, United States
- MERRIMACK PHARMACEUTICALS INC Stake · Cambridge, Massachusetts
- Q32 Bio Inc. Stake · Waltham, Massachusetts
- Social Capital Hedosophia Holdings Corp. VI Stake · Menlo Park, California
- Surface Oncology, Inc. Stake · Cambridge, Massachusetts, United States
- Tectonic Therapeutic, Inc. Stake · Watertown, Massachusetts
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Manager of Issuer's General Partner and Investment Manager.Daniel Schneeberger named Aug 7, 20263
Subsidiaries and ownership
Fund manager
Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.
Timeline
- Nov 7, 2018Founded ADAR1 Partners, LP is founded2
Filings
5 filings to the SEC since October 2021: 5 private raises. The latest 5:
- Aug 7, 2026D/A EDGAR
- Aug 8, 2025D/A EDGAR
- Aug 8, 2024D/A EDGAR
- Aug 8, 2023D/A EDGAR
- Aug 10, 2022D/A EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
ADAR1 Partners, LP has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).
- iBio, Inc.SC 13G Apr 5, 20244
- Q32 Bio Inc.SCHEDULE 13G Mar 14, 20245
- Tectonic Therapeutic, Inc.SCHEDULE 13G Feb 23, 20246
- MERRIMACK PHARMACEUTICALS INCSCHEDULE 13G Feb 22, 20247
- Cellectar Biosciences, Inc.SC 13G Jan 31, 20248
- Surface Oncology, Inc.SC 13G Jul 20, 20239
- Social Capital Hedosophia Holdings Corp. VISC 13G Sep 30, 202210
- FAST Acquisition Corp.SC 13G Jul 27, 202211
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $406.4M
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 2019 | $406.4M | $406.4M |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11